April 07, 2017
Contact: Special Agent Cheryl Davis
Phone Number: (571) 362-1859
Guilty Plea For Southern Ohio Physician Who Ran Prescription Pill Mil
CINCINNATI - Margaret Temponeras, 52, of Portsmouth, Ohio, pled guilty in U.S. District Court to conspiracy to distribute a controlled substance. Temponeras owned the Unique Pain Management Clinic in Wheelersburg, Ohio.
Benjamin C. Glassman, United States Attorney for the Southern District of Ohio, Timothy J. Plancon, Special Agent-in-Charge of the DEA Detroit Field Division, Angela L. Byers, Special Agent-in-Charge, FBI, Steven W. Schierholt, Executive Director, Ohio State Board of Pharmacy, and the Ohio High Intensity Drug Trafficking (HIDTA) announced the plea entered into today before U.S. District Judge Timothy S. Black.
According to the Statement of Facts in this case Temponeras owned and was the physician at Unique Pain Management in Wheelersburg, Ohio. Her father, John Temponeras, 82, was also a physician at the clinic.
From June 2005 until May 2011, Temponeras and her father saw more than 20 patients per day, who paid cash payments starting at $200 for each medical examination. Many patients received monthly prescriptions for similar combinations of medications - namely, 120-150 pills of 15mg Oxycodone, 120-150 pills of 30mg Oxycodone and 90 pills of 2mg Xanax.
Patients were referred to Raymond Fankell, 62, of Wheelersburg, Ohio, who owned Prime Pharmacy, to fill their prescriptions.
Temponeras became aware that some pharmacies in the Scioto County area had declined to accept or fill her prescriptions from Unique Pain Management so she opened the dispensary Unique Relief LLC from the same location as her clinic in order to fill her own prescriptions.
Temponeras and Fankell have each pled guilty to one count of conspiracy to distribute a controlled substance, which is a crime punishable by up to 20 years in prison. John Temponeras pled guilty to one count of conspiracy to distribute oxycodone, which carries the same potential maximum sentence.
U.S. Attorney Glassman commended the investigation of this case by the DEA, FBI, Ohio State Board of Pharmacy, and Ohio HIDTA, as well as Assistant United States Attorneys Timothy D. Oakley and Timothy S. Mangan, who are representing the United States in this case.